稳心颗粒治疗心律失常63例临床观察  

Treatment of 63 cases of arrhythmia with Wenxinkeli

作　　者：李敏[1] 

机构地区：[1]河北省石家庄市第八医院内科,050081

出　　处：《国际中医中药杂志》2010年第3期227-228,共2页International Journal of Traditional Chinese Medicine

摘　　要：目的 观察稳心颗粒治疗心律失常的临床疗效.方法 将126例心律失常患者随机分为两组各63例,治疗组口服稳心颗粒,9 g/次,3次/d;对照组口服胺碘酮,0.2 g/次,3次/d,治疗1周后改为2次/d,继服1周改为1次/d,维持治疗,4周为1个疗程.结果 治疗组总有效率为85.7%,对照组为87.3%,两组总有效率比较,差异无统计学意义（x2=0.068,P〉0.05）.结论 稳心颗粒与胺碘酮抗心律失常作用相近且副作用小,较为安全.Objective To Observe the clinical effects of treating arrhythmia with wenxinkeli.Methods A total of 126 patients with arrhythmia were randomly recruited into a control group and a treatment group,63 cases in each.The treatment group was treated with wenxinkeli 9g/time,3times/d;while the control group was treated with amiodarone,0.2g/time,3 times/d,and changed to 2times/d after one week.Both groups were treated for 4 weeks.Results The total effective rate was 85.7%and 87.3% in control group and the treatment group,showing no significant difference（x2=0.068,P〉0.05）.Conclusion Wenxinkeli has similar antiarrhythmic effects with amiodarone,besides its few side effects.

关 键 词：稳心颗粒 心律失常 疗效 安全性 

分 类 号：R541.7[医药卫生—心血管疾病]